A disturbing report on FDA intransigence from ProPublica: “When COVID-19 started sweeping across America in the spring of 2020, Irene Bosch knew she was in a unique position to help.
“The Harvard-trained scientist had just developed quick, inexpensive tests for several tropical diseases, and her method could be adapted for the novel coronavirus. So Bosc…
